Lu Y - Search Results

1

In vitro evaluation of a Folate-bovine serum albumin-doxorubicin conjugate.

Qu X, Yang C, Zhang J, Ding N, Lu Y, Huang L, Xiang G. Qu X, et al. Among authors: lu y. J Drug Target. 2010 Jun;18(5):351-61. doi: 10.3109/10611860903450049. J Drug Target. 2010. PMID: 20001219

2

Folate receptor-targeted quantum dot liposomes as fluorescence probes.

Yang C, Ding N, Xu Y, Qu X, Zhang J, Zhao C, Hong L, Lu Y, Xiang G. Yang C, et al. Among authors: lu y. J Drug Target. 2009 Aug;17(7):502-11. doi: 10.1080/10611860903013248. J Drug Target. 2009. PMID: 19489689

3

Folate receptor-targeted fluorescent paramagnetic bimodal liposomes for tumor imaging.

Ding N, Lu Y, Lee RJ, Yang C, Huang L, Liu J, Xiang G. Ding N, et al. Among authors: lu y. Int J Nanomedicine. 2011;6:2513-20. doi: 10.2147/IJN.S23934. Epub 2011 Oct 20. Int J Nanomedicine. 2011. PMID: 22072885 Free PMC article.

4

Preparation and in vitro evaluation of a folate-linked liposomal curcumin formulation.

Lu Y, Ding N, Yang C, Huang L, Liu J, Xiang G. Lu Y, et al. J Liposome Res. 2012 Jun;22(2):110-9. doi: 10.3109/08982104.2011.627514. Epub 2012 Feb 28. J Liposome Res. 2012. PMID: 22372871

5

Folate receptor-targeted liposomes enhanced the antitumor potency of imatinib through the combination of active targeting and molecular targeting.

Ye P, Zhang W, Yang T, Lu Y, Lu M, Gai Y, Ma X, Xiang G. Ye P, et al. Among authors: lu y, lu m. Int J Nanomedicine. 2014 May 7;9:2167-78. doi: 10.2147/IJN.S60178. eCollection 2014. Int J Nanomedicine. 2014. PMID: 24855354 Free PMC article.

6

A novel hydrolysis-resistant lipophilic folate derivative enables stable delivery of targeted liposomes in vivo.

Huang Y, Yang T, Zhang W, Lu Y, Ye P, Yang G, Li B, Qi S, Liu Y, He X, Lee RJ, Xu C, Xiang G. Huang Y, et al. Among authors: lu y. Int J Nanomedicine. 2014 Sep 29;9:4581-95. doi: 10.2147/IJN.S69115. eCollection 2014. Int J Nanomedicine. 2014. PMID: 25302024 Free PMC article.

7

Curcumin Micelles Remodel Tumor Microenvironment and Enhance Vaccine Activity in an Advanced Melanoma Model.

Lu Y, Miao L, Wang Y, Xu Z, Zhao Y, Shen Y, Xiang G, Huang L. Lu Y, et al. Mol Ther. 2016 Feb;24(2):364-374. doi: 10.1038/mt.2015.165. Epub 2015 Sep 3. Mol Ther. 2016. PMID: 26334519 Free PMC article.

8

Exploiting in situ antigen generation and immune modulation to enhance chemotherapy response in advanced melanoma: A combination nanomedicine approach.

Lu Y, Wang Y, Miao L, Haynes M, Xiang G, Huang L. Lu Y, et al. Cancer Lett. 2016 Aug 28;379(1):32-8. doi: 10.1016/j.canlet.2016.05.025. Epub 2016 May 25. Cancer Lett. 2016. PMID: 27235608

9

Multi-shelled Dendritic Mesoporous Organosilica Hollow Spheres: Roles of Composition and Architecture in Cancer Immunotherapy.

Yang Y, Lu Y, Abbaraju PL, Zhang J, Zhang M, Xiang G, Yu C. Yang Y, et al. Among authors: lu y. Angew Chem Int Ed Engl. 2017 Jul 10;56(29):8446-8450. doi: 10.1002/anie.201701550. Epub 2017 May 3. Angew Chem Int Ed Engl. 2017. PMID: 28467690

10

MiR-375 delivered by lipid-coated doxorubicin-calcium carbonate nanoparticles overcomes chemoresistance in hepatocellular carcinoma.

Zhao P, Wu S, Cheng Y, You J, Chen Y, Li M, He C, Zhang X, Yang T, Lu Y, Lee RJ, He X, Xiang G. Zhao P, et al. Among authors: lu y. Nanomedicine. 2017 Nov;13(8):2507-2516. doi: 10.1016/j.nano.2017.05.010. Epub 2017 Jun 1. Nanomedicine. 2017. PMID: 28577837

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

48,208 results

Search Page

Filters